UNN Tromsø
Welcome,         Profile    Billing    Logout  
 3 Trials 
7 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Goll, Rasmus
NCT04691544: Donor Versus Autologous Fecal Microbiota Transplantation for Irritable Bowel Syndrome

Active, not recruiting
3
450
Europe
Fecal microbiota transplantation (FMT)
University Hospital of North Norway, Oslo University Hospital, Sorlandet Hospital HF, Haukeland University Hospital, Alesund Hospital
Irritable Bowel Syndrome
09/23
12/26
COLONIZE, NCT03796650 / 2018-004580-31: Fecal Transplantation for Primary Clostridium Difficile Infection

Terminated
3
104
Europe
Fecal microbiota transplantation, FMT, IMT, Bacteriotherapy, Vancomycin
Oslo University Hospital, South-Eastern Norway Regional Health Authority, University Hospital of North Norway, Haukeland University Hospital, Helse Nord-Trøndelag HF, Vestre Viken Hospital Trust, The Hospital of Vestfold, Sykehuset Telemark, Alesund Hospital, University Hospital, Akershus, Lovisenberg Diakonale Hospital, Sorlandet Hospital HF, Ostfold Hospital Trust, Diakonhjemmet Hospital, Nordlandssykehuset HF, Sykehuset Innlandet HF, Helse Stavanger HF
Clostridium Difficile Infection
04/24
04/24
NCT03691987: The Comeback Study

Completed
2
80
Europe
Preprocessed thawed donor FMT, Preprocessed thawed autologous FMT
University Hospital of North Norway, The Research Council of Norway, Quadram Institute Bioscience, Umeå University, Cornell University
Chronic Fatigue Syndrome, Myalgic Encephalomyelitis
03/23
12/23
NCT06233461: A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease

Recruiting
2
268
Europe, Canada, Japan, US, RoW
TAK-279, Zasocitinib, Placebo
Takeda
Crohn's Disease
09/26
07/27
NCT06254950: A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis

Recruiting
2
207
Europe, Canada, Japan, US, RoW
TAK-279, Zasocitinib, Placebo
Takeda
Ulcerative Colitis
09/26
08/27
NCT05660109 / 2022-001656-41: A Study to Assess the Safety of TPM502 in Adults With Celiac Disease

Completed
2
38
Europe, RoW
TPM502, Placebo
Topas Therapeutics GmbH, Topas Therapeutics GmbH
Celiac Disease
07/24
07/24
Nordhus, Kare
EMBRACE, NCT05143138: Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used as a Bridging Stent With Branched and Fenestrated Endografts in the Treatment of Aortic Aneurysms Involving the Renal-Mesenteric Arteries

Active, not recruiting
N/A
259
Europe
GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis
W.L.Gore & Associates
Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm
04/24
07/26

Download Options